← Leaderboards
Karen Kozarsky
Regenx Biosciences, Llc
$1,931,365
Attributed
$3,862,729
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2010–13$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
Funding mix
By agency
NIH$3,862,729 · 5
By mechanism
RC3$2,822,695 · 1
R43$829,025 · 3
R41$211,009 · 1
Top collaborators
- James M Wilson2 shared
- Ronald G Crystal1 shared
- Martin W Lock1 shared
- R Scott Mcivor1 shared
Most similar at Regenx Biosciences, Llc
Same institution · by research overlap
- Martin W Lock$1,093,568
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesDependovirusSerotypingTechnologyVectorTissuesGenomeEvaluationPromotor (Genetics)PersonsRecombinant Adeno-Associated Virus (Raav)GovernmentAdeno-Associated Viral VectorGene ExpressionInheritedCellsCellular TransductionBaseSafetyIn VivoPreventGene Transduction AgentAnimalsGene Transfer
Grant awards (5)
Genetically-delivered Bevacizumab for Treatment of Wet Age-Related Macular Degene$261,327
R43 · FY2013 · EY · contact PI
Novel Adeno-Associated Viral Therapy for Wet Age-Related Macular Degeneration$304,421
R43 · FY2012 · EY · contact PI
AAV Mediated Gene Transfer to the CNS for MPS I$211,009
R41 · FY2012 · DK · contact PI
Novel Adeno-Associated Viral Therapy for X-linked Retinitis Pigmentosa$2,822,695
RC3 · FY2010 · EY · contact PI
Scalable Production of New Generation Adeno-Associated Virus Gene Therapy Vectors$263,277
R43 · FY2010 · DK · contact PI